Should Biotechnology Stock Cassava Sciences Inc (SAVA) Be in Your Portfolio Wednesday?

Cassava Sciences Inc (SAVA) is around the middle of the Biotechnology industry according to InvestorsObserver. SAVA received an overall rating of 51, which means that it scores higher than 51 percent of all stocks. Cassava Sciences Inc also achieved a score of 64 in the Biotechnology industry, putting it above 64 percent of Biotechnology stocks. Biotechnology is ranked 48 out of the 148 industries.

SAVA has an Overall Score of 51. Find out what this means to you and get the rest of the rankings on SAVA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.

Our proprietary scoring system captures technical factors, fundamental analysis and the opinions of analysts on Wall Street. This makes InvestorsObserver’s overall rating a great way to get started, regardless of your investing style. Percentile-ranked scores are also easy to understand. A score of 100 is the top and a 0 is the bottom. There’s no need to try to remember what is “good” for a bunch of complicated ratios, just pay attention to which numbers are the highest.

What’s Happening With Cassava Sciences Inc Stock Today?

Cassava Sciences Inc (SAVA) stock is trading at $25.58 as of 1:03 PM on Wednesday, Feb 22, a rise of $0.37, or 1.47% from the previous closing price of $25.21. The stock has traded between $25.36 and $26.14 so far today. Volume today is less active than usual. So far 288,038 shares have traded compared to average volume of 1,788,504 shares.

Click Here to get the full Stock Report for Cassava Sciences Inc stock.